Background: The prevalence of drug resistance was higher in areas with poor tuberculosis control. Resistance to Anti tuberculosis treatment was found in all 35 countries and regions surveyed. Objective: To Compare of Drug Resistance pattern in cases under supervised vs unsupervised treatment. Study design: Hospital based study. Setting: Department of Pulmonary Medicine, Motilal Nehru Medical College (MLNMC), Allahabad, (U.P) India. Participants: 52 patients. Sampling: Purposive sampling method. Results: Out of 52 patients 23(44.23 %) were relapse, 22(42.30 %) were treatment failure and 7(13.46) were defaulter. Treatment failure cases were more in unsupervised group 28.84% compare with supervised group 13.46%, relapse were more in supervised group 26.9%, as compared to unsupervised group 17.3% and defaulter were more in unsupervised group 11.5%, as compare to supervised group 1.96%. nine patients (17.6%) who took supervised treatment previously were susceptible to all tested drug as compare to unsupervised group in which 3(5.9%) cases were susceptible to all tested drug. 6(11.76%) cases were single drug resistance in supervised group as compared to unsupervised in which 7(13.72%) cases were single drug resistance. Poly resistance were more 12 (23.53%) in unsupervised group as compare to supervised group in which 4(7.84%) cases were poly resistance. Multi drug resistance cases were more 7(7.84%) cases in unsupervised group as compare to supervised group in which 3(5.90%) cases were multi drug resistance Conclusion: It was concluded that supersized strategy was superior to unsupervised treatment in controlling the tuberculosis infection and in preventing the emergence of drug resistance tuberculosis
Resistance to anti tuberculosis treatment was threat to Global Tuberculosis control programme and call for an urgent action to reduce this threat. Increase in migration between countries, international travel and trade and the global HIV Pandemic, all the likely to increase the global burden of drug resistant tuberculosis. [1] Directly observed treatment strategy alone is clearly insufficient for Multi drug resistance Tuberculosis and the outcome of standard short course chemotherapy in this setting remains uncertain. Furthermore, unacceptable failure rates have been reported and resistance to additional agent may be induced. As a result of this there have been calls for well functioning. Directly observed treatment strategy program is engaged to proved additional services in areas with high rates of Multi drug resistance Tuberculosis. World Health Organization in collaboration with other agencies and institution therefore established the working group on directly observed treatment strategy plus for Multi drug resistance Tuberculosis [2, 3] .The present study was carried out to Compare of Drug Resistance pattern in cases under supervised vs unsupervised TB treatment. National Journal of Research in Community Medicine│Oct-Dec 2017│ Vol 6 │Issue 4│
Material & Methods:
The present hospital based study entitled "Comparison of Drug Resistance Pattern under supervised vs unsupervised treatment for tuberculosis" was conducted in the Department of Pulmonary Medicine, Motilal Nehru Medical College, Allahabad, (U.P) India. Patient above 15yr of age attending the OPD of TB and chest disease and other departments of Swroop Rani Nehru hospital and those admitted in TB and chest word of Swroop Rani Nehru hospital, a tertiary health care center were studied. A total of 52 patients, suspect of drug resistant pulmonary tuberculosis i.e who were defaulter, relapse, treatment failure and sputum positive at microscopy centre under RNTCP at SRN hospital Allahabad were studied. Sputum sample of these patients were subjected for culture and sensitivity by radiometric method. Approval for study was passed from the institutional board of study meeting. Purposive sampling i.e. non-random sampling to include subjects that serve the specific purpose was used.
Inclusion criteria:
A TB patient who fail on RNTCP cat I (sputum positive after 5 th month or more).
A TB patient who fail on Cat II DOTS (sputum positive after 4 th month). Failure of Anti tuberculosis treatment in non government organization. Patient who interrupt their treatment for more than 2 month after having received a total of at least 1mt of anti TB treatment and who then return with bacteriologically confirmed TB (Return after default). Patients who continue to be smear positive after the completion of a retreatment regime Patients who have failed a cat IV regime or regime containing second line drugs. Ethical considerations are local cultural values and ideas were respected. Confidentiality was assured. An informed consent was taken before collecting data. The data were collected by using pre-designed and pre-tested semi structured questionnaire. It included information regarding Identification of Patient, HIV Status, Previously treated for TB, Information about previous treatment and outcome of previous treatment.
The enrolled patients were made to under go following investigation: Ziehl Neelsen staining, Culture and sensitivity was done by using radiometric method BACTEC 460. Identification of the Mycobacterium tuberculosis complex is based on the observation that Pnitro alpha acetyl amino-hydroxy beta propiophenone (NAP) will inhibit organisms belonging to the Mycobacterium tuberculosis complex while having little or no effect on other mycobacteria. Test organism inoculated to a BACTEC NAP vial containing 5µg NAP disk displaying a significant increase in the growth index over 5 day incubation period would tend to rule out Mycobacterium tuberculosis complex organism. Data entry and statistical analysis was carried out using SPSS 11.
Numbers and percentages were used. Significant difference was determined using Chi-square test. P-value was calculated using chi-square test and difference was accepted significant at more than 95% (pvalue <0.05).
Results:
Out of total 52 patients, 37 (71.15%) patients belongs to the age of 15 to 45 years and 15(28.84%) were above the age of 45 years. The youngest patient was 18 years of age and the oldest was 75 years of age. (Table1) Among study group, 37(71.15%) patients were male and 15(28.84%) patients were female. 30(57.69 %) patients were belongs to the urban and 22(42.31%) patients were from rural community. All patients (100%) presented with cough with expectoration. This is followed by loss of appetite 50 (96.15 %), fever 48 (92.30 %) and chest pain 24 (46.15 %), hemoptysis was present in 12 (23.07 %) patients. Out of 52 patients, 30(57.69 %) has taken unsupervised treatment (non-DOTS) and 22 (42.30 %) patient has taken supervised treatment (DOTS) .
Out of 52 patients 23(44.23 %) were relapse, 22(42.30 %) were treatment failure and 7(13.46) were defaulter. Treatment failure cases were more in unsupervised group 28.84% compare with supervised group 13.46%, relapse were more in supervised group 26.9%, as compared to unsupervised group 17.3% and defaulter were more in unsupervised group 11.5%, as compare to supervised group 1.96% ( Table 2 ).
In present study nine patients (17.6%) who took supervised treatment previously were susceptible to all tested drug as compare to unsupervised group in which 3(5.9%) cases were susceptible to all tested drug. 6(11.76%) cases were single drug resistance in supervised group as compared to unsupervised in which 7(13.72%) cases were single drug resistance. Poly resistance were more 12 (23.53%) in unsupervised group as compare-National Journal of Research in Community Medicine│Oct-Dec 2017│ Vol 6 │Issue 4│ to supervised group in which 4(7.84%) cases were poly resistance. Multi drug resistance cases were more 7(7.84%) cases in unsupervised group as compare to supervised group in which 3(5.90%) cases were multi drug resistance. (Table 3) Out of 51 patient 10 (19.6%) patients were two drug resistance. The most common two drug combination pattern was isoniazid and ethambutol in 4(7.84%) patients followed by isoniazid and Pyrazinamide in 2(3.92) patients and in 1(1.96%) patients each of HR, RS, ZS and ES. One patient (1.96%) was Multi-drug Resistant Tuberculosis. (Table 4) Discussion:
The present study was under taken to evaluate the acquired drug resistance pattern in previously treated patients. The present study includes 52 patients. Culture was done in all these patients by radiometric method. Sensitivity was done in 51 patients for the five first line drugs.
Maximum cases 29(55.76%) were in age group (15-35) year as observed by Desiree TB D'souza [4] 66%. Males 37 (71.15%) predominate over female as observed by Desiree TB D'souza 60%. Out of 52 cases 30 (57.69%) belong to urban areas while 22 (42.30%) to rural area. More number of urban cases is due to the tertiary care centre facility.
Nine patients (17.6%) who took supervised treatment previously were susceptible to all tested drug as compare to unsupervised group in which 3(5.9%) cases were susceptible to all tested drug. 6(11.76%) cases were single drug resistance in supervised group as compared to unsupervised in which 7(13.72%) cases were single drug resistance. Poly resistance were more 12 (23.53%) in unsupervised group as compare to supervised group in which 4(7.84%) cases were poly resistance. Multi drug resistant cases were more 7(7.84%) cases in unsupervised group as compare to supervised group in which 3(5.90%) cases were multi drug resistance.
Anuradha B concluded in our study that acquired resistance to isoniazid was in 18(9.2%) cases rifampicin resistance was in 14(7.2%), Ethambutol resistance was in 8(4.1%) cases and streptomycin resistance was in 9(4.6%) acquired Multi drug resistant tuberculosis cases was in 11 (5.6%) cases. [5] Javed A Malik et al (2008) [11] concluded from our study that of the 69 patients 20 (28.9%) were resistant to one or more than one drug, 49(71.1%) were susceptible to all tested drugs. Multi drug resistant tuberculosis strain was found in 17(24.6%) cases and other drug resistance in 3(15%). [6] Janmeja concluded from our study that in 200 patients of treatment failure, 75% revealed resistance to one or more anti tuberculosis drug. Resistance to isonaizid was observed in 72% cases it was 49% for rifampicin and 73% for National Journal of Research in Community Medicine│Oct-Dec 2017│ Vol 6 │Issue 4│ streptomycin, multi drug resistance tuberculosis was seen in 59% cases [7] . Malhotra B et al (2002) [13] concluded from our study that acquired drug resistance was detected in 22/78 (28.2%) to rifampicin, in 31/78(39.7%) to isoniazid and in 19/78 (24.3%) for both. [8] Desiree TB D'souza concluded from our study that a high proportion of Multi drug resistant tuberculosis and polyresistance 41% and 26% respectively was observed in previously treated cases, mono resistance to isoniazid was in 7% cases, rifampicin was in 2% case and for pyrazinamide was in 4% cases. [4] Data documented at TUBERCULOSIS RESEARCH CENTRE Chennai from 443 cat II patients revealed that the prevalence of Multi drug resistant tuberculosis was 11.7%.
Multi drug resistant tuberculosis strain present in range between 9.2% to 41%. Our results lies between this range i.e. 19.6%. Present study results were comparable with the study of Mathur B (24.3%) and Dam. T(14%). [9] Present study results was higher than the study of Saha(9.2%). [6] Our results are lower than Deivanayagan [10] and Desiree TB D'souza. [4] Conclusion: It was concluded that supersized strategy was superior to(p value <0.05) unsupervised treatment in controlling the tuberculosis infection and in preventing the emergence of drug resistance tuberculosis. Although a well-administered directly observed treatment strategy is the best method of preventing drug resistance and eventual treatment failure, it may not adequately treat resistant case. There is an urgent need for timely identification of suspect of Drug resistance by early referral for culture and Drug sensitivity test for prompt initiation of appropriate treatment to improve outcome as well as to sever the chain of transmission In present study nine patients (17.6%) who took supervised treatment previously were susceptible to all tested drug as compare to unsupervised group in which 3(5.9%) cases were susceptible to all tested drug. 6(11.76%) cases were single drug resistance in supervised group as compared to unsupervised in which 7(13.72%) cases were single drug resistance. Poly resistance were more 12 (23.53%) in unsupervised group as compare to supervised group in which 4(7.84%) cases were poly resistance. Multi drug resistance cases were more 7(7.84%) cases in unsupervised group as compare to supervised group in which 3(5.90%) cases were multi drug resistance.
